Clinical Trial Update: Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating molecular imaging with PET/CT to understand the mechanism of cardiotoxicity in patients with light-chain (AL) amyloidosis has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Cardiac Amyloidosis

Snippet

Sponsor: University of Pennsylvania | Conditions: Cardiac Amyloidosis | EARLY_Phase 1 | Status: TERMINATED